Pacira BioSciences, Inc. SEC filings PCRX

Pacira BioSciences, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Mar 31, 2014. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.

Pacira BioSciences, Inc. SEC filings
Form Description Filed Period
SC 14D9/A Filing Nov 3, 2026 —
SC 14D9 Filing Oct 30, 2026 —
SC TO-T Filing Oct 30, 2026 —
SC TO-C Filing Oct 8, 2026 —
SC14D9C Filing Oct 8, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Oct 8, 2026 Oct 8, 2026
SC TO-C Filing Oct 8, 2026 —
S-8 Employee stock plan registration Aug 4, 2026 —
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jun 30, 2026 Jun 28, 2026
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 11, 2026 Jun 9, 2026
DEFA14A Additional proxy material Jun 4, 2026 —
DEFA14A Additional proxy material Jun 1, 2026 —
DFAN14A Filing May 28, 2026 —
DEFA14A Additional proxy material May 28, 2026 —
DEFA14A Additional proxy material May 27, 2026 —
DEFA14A Additional proxy material May 26, 2026 —
DFAN14A Filing May 21, 2026 —
DEFA14A Additional proxy material May 20, 2026 —
DFAN14A Filing May 20, 2026 —
DEFA14A Additional proxy material May 20, 2026 —
DEFA14A Additional proxy material May 13, 2026 —
DFAN14A Filing May 13, 2026 —
DEFC14A Filing May 12, 2026 —
DFAN14A Filing May 12, 2026 —
DEFA14A Additional proxy material May 12, 2026 —
PRRN14A Filing May 8, 2026 —
DEFA14A Additional proxy material May 5, 2026 —
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
PRRN14A Filing Apr 30, 2026 —
DEFA14A Additional proxy material Apr 28, 2026 —
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFC14A Form defc14a Apr 28, 2026 —
PREC14A Form- prec14a Apr 17, 2026 —
DFAN14A Filing Mar 12, 2026 —
DEFA14A Additional proxy material Mar 11, 2026 —
DFAN14A Filing Mar 11, 2026 —
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 28, 2026 Jan 27, 2026
DFAN14A Amendment no. 1 Jan 9, 2026 —
8-K Current report
Results of operations
Jan 8, 2026 Jan 8, 2026
DFAN14A Filing Dec 30, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
S-8 Employee stock plan registration Aug 5, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Jul 10, 2025 Jul 9, 2025
8-K Current report
Material agreement, Agreement ended, New debt
Jul 7, 2025 Jul 3, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2025 Jun 10, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 10, 2024
8-K Current report
Other events
Apr 22, 2025 Apr 17, 2025
DEFA14A Additional proxy material Apr 18, 2025 —
DEFA14A Additional proxy material Apr 17, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 7, 2025 Apr 7, 2025
8-K Current report
Bylaw or fiscal year change
Mar 14, 2025 Mar 12, 2025
DEFA14A Additional proxy material Mar 14, 2025 —
DFAN14A Filing Mar 14, 2025 —
S-8 Employee stock plan registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 30, 2025 Jan 28, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 21, 2025 Jan 16, 2025
8-K Current report
Results of operations
Jan 10, 2025 Jan 10, 2025
DFAN14A Filing Dec 11, 2024 —
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations, Officer or director change
Nov 6, 2024 Oct 31, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 21, 2024 Oct 16, 2024
8-K Current report
Officer or director change
Sep 27, 2024 Sep 26, 2024
8-K Current report
Other events
Sep 9, 2024 Sep 3, 2024
8-K Current report
Other events
Aug 9, 2024 Aug 9, 2024
10-Q Quarterly report Jul 30, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 30, 2024 Jul 30, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2024 Jun 11, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
May 14, 2024 May 9, 2024
8-K Current report
Material agreement, New debt, Other events
May 8, 2024 May 8, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations, Other events
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 22, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 22, 2024 —
DEF 14A Proxy statement Apr 22, 2024 Jun 11, 2024
S-8 Employee stock plan registration Feb 29, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Feb 29, 2024 Feb 26, 2024
8-K Current report
Results of operations
Jan 4, 2024 Jan 4, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 21, 2023 Dec 20, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
UPLOAD Letter from the SEC Oct 24, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 10, 2023 Oct 6, 2023
CORRESP Letter to the SEC Oct 6, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 26, 2023 Sep 20, 2023
UPLOAD Letter from the SEC Sep 22, 2023 —
8-K Current report
Other events
Sep 11, 2023 Sep 7, 2023
S-8 Employee stock plan registration Aug 2, 2023 —
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 20, 2023 Jun 13, 2023
10-Q Quarterly report May 3, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
ARS Annual report to shareholders Apr 21, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 21, 2023 —
DEF 14A Proxy statement Apr 21, 2023 —
8-K Current report
Material agreement, Agreement ended, New debt, Other events
Apr 3, 2023 Mar 31, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 22, 2023 Mar 18, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Results of operations
Jan 5, 2023 Jan 5, 2023
8-K Current report
Results of operations
Dec 13, 2022 Dec 13, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Results of operations
Oct 13, 2022 Oct 13, 2022
8-K Current report
Results of operations
Sep 13, 2022 Sep 13, 2022
8-K Current report
Results of operations
Aug 10, 2022 Aug 10, 2022
S-8 Employee stock plan registration Aug 4, 2022 —
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Results of operations
Jul 14, 2022 Jul 14, 2022
8-K Current report
Results of operations
Jun 14, 2022 Jun 14, 2022
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 10, 2022 Jun 7, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations, Officer or director change
May 4, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 22, 2022 —
DEF 14A Proxy statement Apr 22, 2022 Jun 7, 2022
8-K Current report
Results of operations
Apr 12, 2022 Apr 12, 2022
8-K Current report
Results of operations
Mar 15, 2022 Mar 15, 2022
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Results of operations
Feb 15, 2022 Feb 15, 2022
8-K/A Amended current report Feb 7, 2022 Nov 19, 2021
8-K Current report
Results of operations
Jan 6, 2022 Jan 6, 2022
8-K Current report
Material agreement, New debt, Other events
Dec 9, 2021 Dec 6, 2021
8-K Current report
Results of operations
Dec 7, 2021 Dec 7, 2021
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Nov 19, 2021 Nov 19, 2021
SC TO-T/A Filing Nov 19, 2021 —
SC TO-T/A Filing Nov 18, 2021 —
SC TO-T/A Filing Nov 12, 2021 —
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 3, 2021 Nov 3, 2021
SC TO-T/A Filing Nov 1, 2021 —
SC TO-T Filing Oct 22, 2021 —
SC TO-C Filing Oct 12, 2021 —
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Oct 12, 2021 Oct 11, 2021
8-K Current report
Results of operations
Sep 15, 2021 Sep 15, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
S-8 Employee stock plan registration Aug 3, 2021 —
10-Q Quarterly report Aug 3, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 3, 2021 Aug 3, 2021
8-K Current report
Results of operations
Jul 13, 2021 Jul 13, 2021
8-K Current report
Officer or director change
Jun 17, 2021 Jun 16, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2021 Jun 8, 2021
8-K Current report
Results of operations
Jun 8, 2021 Jun 8, 2021
8-K Current report
Results of operations
May 11, 2021 May 11, 2021
10-Q Quarterly report May 4, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 4, 2021 May 4, 2021
DEF 14A Proxy statement Apr 22, 2021 Jun 8, 2021
DEFA14A Additional proxy material Apr 22, 2021 —
8-K Current report
Results of operations
Apr 7, 2021 Apr 7, 2021
8-K Current report
Regulation FD disclosure
Mar 23, 2021 Mar 22, 2021
8-K Current report
Results of operations
Mar 9, 2021 Mar 9, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Results of operations
Feb 10, 2021 Feb 10, 2021
8-K Current report
Results of operations
Jan 7, 2021 Jan 7, 2021
8-K Current report
Results of operations
Dec 9, 2020 Dec 9, 2020
8-K Current report
Officer or director change
Dec 7, 2020 Dec 4, 2020
8-K Current report
Results of operations
Nov 12, 2020 Nov 11, 2020
10-Q Quarterly report Oct 30, 2020 Sep 30, 2020
8-K Current report
Results of operations
Oct 29, 2020 Oct 29, 2020
8-K Current report
Results of operations
Oct 7, 2020 Oct 7, 2020
8-K Current report
Results of operations
Sep 9, 2020 Sep 9, 2020
CT ORDER Filing Aug 17, 2020 —
8-K/A Amended current report
Results of operations
Aug 6, 2020 Aug 6, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jul 10, 2020 Jul 10, 2020
8-K Current report
Results of operations
Jul 6, 2020 Jul 6, 2020
8-K Current report
Agreement ended, Regulation FD disclosure
Jul 2, 2020 Jul 2, 2020
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2020 Jun 5, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 24, 2020 —
DEF 14A Proxy statement Apr 24, 2020 Jun 8, 2020
CT ORDER Filing Apr 10, 2020 —
10-K Annual report Feb 21, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 20, 2020 Feb 20, 2020
8-K Current report
Officer or director change
Jan 10, 2020 Jan 10, 2020
8-K Current report
Results of operations
Jan 9, 2020 Jan 9, 2020
CT ORDER Filing Dec 6, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PCRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Brisbane, CA
SEC filer status
Large accelerated filer
SEC CIK
1396814
Former names
Pacira Pharmaceuticals, Inc. (until Apr 9, 2019); PACIRA INC (until Nov 5, 2008); Blue Acquisition Corp (until Apr 16, 2007)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.